Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUTI-16 in Asymptomatic HIV-1 Infected Subjects
NCT00848211Phase 2Completed
- Sponsor
- Thymon
- Start
- Feb 2009
- Primary completion
- May 2010
- Modality
- Cyclic Peptides, Vaccines & Immunotherapeutics, Peptide Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of TUTI-16 in human immunodeficiency virus infection (HIV), sponsored by Thymon. Started Feb 2009; status: completed.
02
Drugs
TUTI-16
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00848211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848211.